MEDP

Jefferies Upgrades Medpace Holdings (MEDP)

Fintel reports that on February 13, 2026, Jefferies upgraded their outlook for Medpace Holdings (NasdaqGS:MEDP) from Hold to Buy.

Analyst Price Forecast Suggests 30.24% Upside

As of February 4, 2026, the average one-year price target for Medpace Holdings is $557.47/share. The forecasts range from a low of $341.82 to a high of $693.00. The average price target represents an increase of 30.24% from its latest reported closing price of $428.03 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Medpace Holdings is 2,276MM, a decrease of 10.05%. The projected annual non-GAAP EPS is 12.01.

What is the Fund Sentiment?

There are 1,156 funds or institutions reporting positions in Medpace Holdings. This is an decrease of 26 owner(s) or 2.20% in the last quarter. Average portfolio weight of all funds dedicated to MEDP is 0.26%, an increase of 5.99%. Total shares owned by institutions decreased in the last three months by 6.71% to 27,148K shares. MEDP / Medpace Holdings, Inc. Put/Call Ratios The put/call ratio of MEDP is 1.04, indicating a bearish outlook.

What are Other Shareholders Doing?

Aqr Capital Management holds 1,025K shares representing 3.61% ownership of the company. In its prior filing, the firm reported owning 621K shares , representing an increase of 39.42%. The firm decreased its portfolio allocation in MEDP by 43.21% over the last quarter.

IJH - iShares Core S&P Mid-Cap ETF holds 768K shares representing 2.70% ownership of the company. In its prior filing, the firm reported owning 815K shares , representing a decrease of 6.12%. The firm decreased its portfolio allocation in MEDP by 8.49% over the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 738K shares representing 2.60% ownership of the company. In its prior filing, the firm reported owning 768K shares , representing a decrease of 4.07%. The firm decreased its portfolio allocation in MEDP by 11.69% over the last quarter.

Geode Capital Management holds 667K shares representing 2.35% ownership of the company. In its prior filing, the firm reported owning 643K shares , representing an increase of 3.69%. The firm decreased its portfolio allocation in MEDP by 41.51% over the last quarter.

Wasatch Advisors holds 648K shares representing 2.28% ownership of the company. In its prior filing, the firm reported owning 926K shares , representing a decrease of 42.83%.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.